Kelly Gatfield
Group Leader & Scientific Leader GlaxoSmithKline
Seminars
Wednesday 23rd September 2026
Enhancing Automated Ion Channel Electrophysiology to Support Drug Discovery
11:30 am
- Exploring the transformative role of automated electrophysiology platforms in high-throughput ion channel screening for drug discovery
- Detailing the application of these technologies in early safety profiling to efficiently detect cardiotoxic and neurotoxic risks, with a goal to minimizing late-stage attrition
- Discussing strategic screening approaches to identify potent, selective, and safe modulators, enhancing mechanistic understanding and expediting therapeutic development
